Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease'. Together they form a unique fingerprint.

Medicine & Life Sciences